VIR BIOTECHNOLOGY, INC. (VIR) Social Stream
Vir Biotechnology Inc (VIR) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Vir Biotechnology Inc.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-21 | 6 | $300 | $36 | $96.333 | $33.14 | 190.68% |
| 2021-11-11 | 5 | $135 | $36 | $75.4 | $33.14 | 127.52% |
| 2021-11-30 | 5 | $200 | $36 | $88.4 | $33.14 | 166.75% |
| 2021-11-30 | 6 | $200 | $36 | $88.4 | $33.14 | 166.75% |
| 2021-11-05 | 5 | $135 | $37 | $75.6 | $33.14 | 128.12% |
The Trend in the Analyst Price Target
Over the past 50 weeks, VIR's average price target has gone up $41.47.
Over the past 47 weeks, VIR's average upside potential has been 76.03%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-05 | 7 | 135 | 45 | 81.17 | 37.71 | 115.25% |
| 2021-09-18 | 7 | 135 | 29 | 69.86 | 54.54 | 28.09% |
| 2021-02-06 | 3 | 125 | 54 | 74.40 | 66.72 | 11.51% |
| 2021-07-10 | 7 | 135 | 45 | 81.17 | 39.01 | 108.07% |
| 2021-11-30 | 5 | 200 | 36 | 88.40 | 47.42 | 86.42% |
VIR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 4 | 0 | 1 | 1 | 1 | 6 |
The Trend in the Broker Recommendations
Over the past 61 days, VIR's average broker recommendation rating improved by 0.14.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, Vir Biotechnology Inc's variance in analysts' estimates is lower than -394.39% of them.
- VIR has a higher upside potential (average analyst target price relative to current price) than 438.54% of stocks in the mid market cap category.
- In the context of Pharmaceutical Products stocks, Vir Biotechnology Inc's average analyst price target is higher than 418.93% of them.
- In the context of stocks in the mid market cap category, Vir Biotechnology Inc's number of analysts covering the stock is higher than 153.05% of them.
Stocks similar to Vir Biotechnology Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VCEL, TIL, and SWTX.
Is VIR a Buy, Hold or Sell? See the POWR Ratings now!